Publication | Closed Access

Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity

Antimicrobial SusceptibilityAntibioticsMedicineCompound Design GuidelinesEscherichia ColiPermeation BarriersAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundPharmacologyAntimicrobial ResistanceDrug Resistance